Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR.
Sena KimKidist AshamiSora LimKarl StaserKiran VijSrikanth SanthanamJulie RitcheySarah PetersonFeng GaoMatthew A CiorbaMatthew L CooperJohn F DipersioJaebok ChoiPublished in: Leukemia (2021)